The pre-gestational pathway was very little used, however, accounting for only 2% of the appointments made with the services involved. In conclusion, the key to success in managing pregnancy in obese women lies in sharing the various different health care competences required and taking the local resources into account. The prevention of obesity in women of fertile age remains the main problem, however, and further efforts are needed in this setting.
Introduction
The rate of obesity among women of child-bearing age is increasing dramatically in many Western countries [1] [2] [3] . In addition, the rising prevalence of obesity worldwide has been accompanied by an increase in the average weight gained during pregnancy [4] .
Obesity during pregnancy can adversely affect the immediate wellbeing of the mother and the newborn, as well as the latter's long-term health [5] . According to the CEMACH report, obese mothers have a 50% higher prenatal and peripartum mortality rate than women of normal weight [6] . Maternal pre-conception body mass index (BMI) has also been associated with comorbidities such as gestational diabetes mellitus (GDM) [7] , gestational hypertension, preeclampsia [8] , cesarean delivery [9] , wound breakdown, and venous thromboembolism. As concerns the mothers' weight gain prior to pregnancy, it was demonstrated that women who gained 2.3-10 kg per year had a 2.5-fold higher risk of GDM than women whose weight remained stable [7] . In terms of fetal outcomes, a high maternal pre-conception BMI has been correlated with high rates of spontaneous abortion, congenital malformations, and infants large for gestational age (LGA) [9] [10] [11] . Preconception counseling, careful prenatal management, close monitoring of weight gain, and a strict follow-up during pregnancy are essential for obese fertile women planning to have children in order to prevent the negative effects of obesity [12, 13] .
In the Veneto region (northeast Italy), the public health system is administered through 21 Local Social and Healthcare Authorities (LHAs), which provide government-funded healthcare. The system assures a universal coverage with a per-capita financing system, providing for prevention, primary care, and hospital care. The city of Padua (LHA No. 16) has numerous different secondary and tertiary care services specifically dedicated to the assessment and care of patients with obesity and to high-risk pregnancies.
Calculating that about 400 obese women may become pregnant in Padua every year, we developed a project consisting in the creation of an integrated network of primary, secondary, and tertiary care providers and the design of new clinical pregestational and gestational pathways for managing pregnancy in obese women. We report here on the preliminary results of this project.
Methods

Formulation of the clinical pathways
We appointed a steering committee involving medical doctors working at the Diabetology and Dietetics Unit and the Obesity Center of the University of Padua, Department of Medicine, the Obstetrics and Gynecology Clinics at Padua General Hospital, the territorial Gynecology and Family Health Services, and the Padua LHA management. This steering committee reviewed current knowledge on pregnancy management in obese women and the resources locally available [12] [13] [14] [15] [16] [17] [18] [19] [20] . The committee developed a first draft envisaging two different clinical pathways: a pregestational pathway for programming pregnancy in obese women; and a gestational pathway for the clinical management of pregnancy in obese women. The committee shared the draft with a broader group of medical doctors and other professionals working at outpatient and hospital services in the area to reach a preliminary consensus. After reaching a consensus a therapeutic and clinical care assistance pathway was developed and validated in the following 6 months.
Patient care
In obese pregnant women included in the gestational pathway, weight, BMI, and blood pressure are monitored closely throughout the pregnancy, as well as proteinuria and renal and hepatic function, because obese women are at higher risk of hypertension, preeclampsia, and eclampsia. At their first appointment at POCU women receive a multidisciplinary consultant-led care from an endocrinologist-diabetologist, a dietician, and a midwife. The dietician provides obese pregnant women with tailored nutritional advice to promote a healthy weight gain and an adequate supply of nutrients to mother and fetus. At each visit women are weighed, their blood pressure is measured, the nutritional advices are reviewed, and they are counseled about maternal and fetal risks related to obesity in pregnancy. Between 16-18 and 24-28 weeks of gestation, the women are screened for GDM, as recommended by national and international guidelines [12, 16] . If GDM is diagnosed, the women are included in the Pregnancy and GDM pathway managed at the Diabetology and Dietetics Unit.
All women then have access to services equipped with the gynecologist and with the technology needed to conduct obstetric sonograms capable of monitoring the health of the fetus in severely obese women. During their first antenatal examination, and periodically throughout the pregnancy, such women are also assessed by the obstetrician and the anesthesiologist to predict any difficulties during delivery relating to venous access, anesthesia (local, general), and the risk of thromboembolic events.
The obese women that would plan a pregnancy and are included in the pregestational pathway at their first appointment at the POCU at Diabetology and Dietetics Unit receive a multidisciplinary consulant-led care from an endocrinologist-diabetologist, a dietician, and a midwife. As for laboratory evaluation, a blood test, including lipid profile, fasting blood glucose, uric acid, serum creatinine, and TSH is performed. Then these woman are assessed from a clinical and nutritional standpoint. A tailored nutritional advice, defining her acceptable weight, and the timing of her weight loss so that she can start her pregnancy once she has achieved an acceptable weight is offered. The progress is assessed at follow-up visits. Supplementation with folic acid (5 mg) is started at least a month before conception. If bariatric surgery is indicated, the patient is managed jointly with the Obesity Center, following the pathway currently used [21, 22] .
At their first appointment, a gynecological examination and assessment of any issues relating to fertility and pregnancy is also programmed.
The pathway ends when the woman reaches a weight judged acceptable for conception, or if she becomes pregnant.
Data collection
Data were collected on the number of times women accessed the services involved in the pathways; furthermore, in women attending the gestational pathway we take into consideration ethnicity, height, body mass index (BMI, kg/m 2 ), frequency of GDM, weight gain during pregnancy, time and mode of delivery, birthweight, macrosomia, large for gestational age (LGA, according with national charts for weight and sex and gestational age), [23] infants were considered. As control group 120 non selected pregnant women followed at the POCU before the starting of the pathways were considered; these women have been treated even if less intensively.
All the women were asked to complete a questionnaire assessing any problems they encountered in accessing these services, and their satisfaction with the care they received.
The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice guidelines; informed consent was obtained from all individual participants included in the study.
Statistical evaluation
Data are expressed as mean ± standard deviation (SD) or percentual values. Differences between groups have been evaluated by Student's t test and χ 2.
Results
The pathways
The gestational pathway was the first diagnostic and therapeutic pathway to be identified by the working group (Fig. 1) and was designed to deal with obese women who were already pregnant.
Using a pathway-specific agenda, the gynecologist who first sees an obese pregnant woman (a prepregnancy BMI ≥ 30) books her an appointment at the Pregnancy in Obesity Care Unit (POCU) at Diabetology and Dietetics Unit, which has a special service for pregnancy in obesity. The second diagnostic and therapeutic pathway identified by the working group (Fig. 2) was the pre-gestational pathway, which deals with the planning of pregnancy in obese women.
Obese women in Pregnancy
Any physician (general practitioner, gynecologist, specialist in aspects of general medicine, diabetologist, endocrinologist) who examines an obese woman wishing to become pregnant can make an appointment for her: Here again, the doctor uses a pathway-specific agenda and provides the woman with prescriptions for the tests she needs to have done before the going to her appointment.
The two pathways were gradually implemented by the team, starting in October 2015. Figure 3 shows the trend of the access to the Pregnancy in Obesity Service at Diabetology and Dietetics Unit. First and follow-up visits are shown, revealing a gradual increase in the access rate; in particular 98% of the visits (two patients) are related to pregnant obese women. It is worth noting that 61% of the pregnant women involved are immigrants. In principle, pregnant women were followed from the 6-8 g.w. until delivery, with a mean of four medical examinations and eight dietician evaluations.
Concerning the answers given in the questionnaire, the vast majority of respondents (90%) said they had heard from their gynecologist about the Pregnancy in Obesity Service while only 10% of the women received this information from their general practitioner. On the whole, respondents were satisfied (34%) or very satisfied (60%) with the care they 
The patients
In all, 76 obese pregnant women were followed in the first 6 months; their clinical and metabolic characteristics and pregnancy outcome are described in Table 1 . Compared to control group, the women followed with POCU showed a significant lower rate of GDM and a reduction in LGA and cesarean section did not reach statistical significance. The obese pregnant women followed according with the new clinical pathway show a weight gain in line with the Institute of Medicine recommendations (Fig. 4) .
Discussion
The prevalence of obesity is rising in the developed world, leading to obesity in women of fertile age becoming one of the most common high obstetric risks due to the known deleterious effects of obesity on the outcome of pregnancy [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Given the heavy medical and economic consequences of pregnancy in obese women, attempts must be made to prevent obesity in women of childbearing age and to encourage obese women to lose weight before they become pregnant. In an effort to achieve this aim, we developed a project to involve primary, secondary, and tertiary care providers in designing appropriate clinical pathways for taking care of pregnancy in obese women [12, 13] . The work of the steering committee (described in the "Methods" section) started with an analysis of the latest guidelines on pregnancy in obesity currently available [12] [13] [14] [15] [16] [17] [18] [19] [20] . This enabled the committee to decide the most important points to consider for the purpose of: counseling obese women of childbearing age: carefully following up pregnancies in obese women; providing appropriate tools for screening these women for potential complications, such as GDM, risk factors for preeclampsia, thromboembolism, and so on; and dietary counseling to achieve a correct weight gain during pregnancy. The issue of counseling is crucial because experience of providing routine antenatal nutritional services for women with obesity has clearly shown that these women attributed a great deal of importance to the information and advice they received personally from the health professionals and felt that tailoring the recommendations they received to their specific personal circumstances helped them to make the necessary changes to their diet and level of physical activity for the benefit of fetal development [23] .
After reaching a consensus on the most important provisions to be made for pregnant obese women, the committee's next step was to test their practical implementation using the locally available healthcare resources [12] [13] [14] [15] [16] [17] [18] [19] [20] . The two proposed clinical pathways were discussed at several meetings with an expanded group of physicians and professionals working with the outpatients and hospital services to reach a broad consensus. The results of our study suggest that our gestational pathway was generally successful. The number of women using the pathway gradually increased, and no problems with accessing the services were reported. The fact that immigrant women accounted for 60% of the pathway users is important because it is well known that immigrants can find it more difficult to access the healthcare services available due to language issues or cultural and religious differences. This can pose a number of problems with a bearing on quality of care, wellbeing, and maternal and fetal outcomes [24, 25] . The patients expressed a high level of satisfaction with the services they received. This is also very important because women with obesity often consider the recommendations concerning lifestyle changes that they receive from healthcare professionals to be unrealistic due to their constrained social circumstances [26] . The multidisciplinary teams that take care of obese pregnant women need to bear this aspect in mind.
Considering then the data related to the outcome of pregnancy it is to be noted that, with respect to control group, women enrolled in the pathway and followed at POCU showed a significant lower rate of GDM, and a reduction in LGA and cesarean section that did not reach statistical significance probably for the scarce number of patients evaluated until now. Interestingly, the obese pregnant women followed according with the new clinical pathway show a weight gain in line with the Institute of Medicine recommendations. Literature data show that among obese women up to 66% of nulliparous women and 56% of multiparous women experience gestational weight gain that exceed the IOM guidelines [27] .
The pre-gestational pathway seemed to have much less impact. Generally speaking, women of fertile age see their general practitioners or consult a gynecologist when they are already pregnant or if they experience difficulty in conceiving. Since 90% of the women answering our questionnaire said they received information about the services available to them from the gynecologist, it follows that general practitioners need to be involved much more effectively in order to be able to take preventive action in the setting of pregnancy in obesity.
Our study has some limitations, due mainly to the fact that the results discussed here are only preliminary. Is well known that maternal BMI determines maternal and neonatal negative outcomes, an increase in numbers and duration to maternal admission in hospital, and an increase in the health service costs [28] . Our data are preliminary and do not allow any speculation on the cost-benefit issues relating to our pathways.
The multidisciplinary team lacks a psychologist and a physiatric but we are working so to have also these professionals in the team.
The novelty of the study lies in the complexity and highly specialized content of the pathways designed.
In conclusion, the preliminary results of implementing specific clinical pathways for obese women in pregnancy suggest that sharing the various different competences required and making good use of the local healthcare resources are the key to success in this context. The prevention of obesity in women of fertile age remains an evergrowing problem, however, and every effort must be made to deal with this issue.
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